Skip to main content
. 2016 Jan;71(1):5–9. doi: 10.6061/clinics/2016(01)02

Table 2.

Causes of premature discontinuation (n=56).

Cause Eszopiclone n (%) n=25 Zopiclone n (%) n=31
Comorbidity 1 (4.0) -
Non-adherence to the protocol or treatment 5 (20.0) 4 (12.9)
Follow-up loss 1 (4.0) 2 (6.4)
Refusal to continue treatment 3 (12.0) 4 (12.9)
Withdrawal of consent 2 (8.0) 2 (6.4)
Intolerance to study medication 9 (36.0) 15 (48.4)
Other sleep-affecting drug use 4 (16.0) 4 (12.9)